Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Innoviva Inc

INVA
15,79
0,44 (2,87%)
01 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/5/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202402:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202415:27EDGAR2Form 8-K - Current report
08/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:44EDGAR2Form 8-K - Current report
08/5/202422:05BWInnoviva Reports First Quarter 2024 Financial Results;..
08/5/202413:00BWInnoviva to Participate in the BofA Securities Health Care..
24/4/202413:00BWInnoviva Specialty Therapeutics’ Positive Phase 3 Oral..
08/3/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:15EDGAR2Form 8-K - Current report
29/2/202422:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
23/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202402:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:30EDGAR2Form 8-K - Current report
01/11/202321:30EDGAR2Form 8-K - Current report
01/11/202321:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
01/11/202321:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
19/9/202314:30BWInnoviva to Participate in the Cantor Global Healthcare..
18/9/202314:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
01/9/202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:24EDGAR2Form 8-K - Current report
25/8/202322:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
07/8/202322:42EDGAR2Form 8-K - Current report
03/8/202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:15EDGAR2Form 8-K - Current report
02/8/202322:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
11/7/202314:16EDGAR2Form 8-K - Current report
06/6/202322:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
Apertura: 15,50 Min: 15,37 Max: 15,83
Chiusura: 15,35

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network